Compare UBC Medical Indonesia Tbk. (LABS) vs Destinasi Tirta Nusantara Tbk (PDES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Destinasi Tirta Nusantara Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Destinasi Tirta Nusantara Tbk trades at Rp404 (market cap 290.29B, 1.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 1.2K). Which is the better fit depends on your goals.
| LABS | PDES | |
|---|---|---|
Market Cap | 576.7B | 290.29B |
Volume | 3.48M | 1.2K |
Lot | 34.82K | 12 |
Turnover | 522.79M | 482.8K |
Average Price | 150.13 | 402.33 |
Value | 522.79M | 482.8K |
Indicative Equilibrium Price | 148 | 404 |
Indicative Equilibrium Volume | 350 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Read more on PDES →
